Skip to main content
OpenTrials

Clinical trial condition

Hepadnaviridae Infections

Explore clinical trials studying Hepadnaviridae Infections. Study availability and eligibility vary by location and protocol.

1,149 public trials 113 recruiting studies
Refine in advanced search Browse all conditions

Hepadnaviridae Infections trial results

Completed

Qidong Hepatitis B Intervention Study

NCT00222664

Conditions
Adenocarcinoma, Blood-Borne Infections, Carcinoma, +17 more
Locations
  • Qidong Liver Cancer Institute Qidong, Jiangsu, China
  • Cancer Institute, Chinese Academy of Medical Sciences Beijing, China
  • Clinical Trial Service Unit and Epidemiological Studies Unit Oxford, United Kingdom
View Trial Details
Active, Not Recruiting

Study of Bepirovirsen in Participants Living With Human Immunodeficiency Virus and Chronic Hepatitis B Virus Infection (B-Focus)

NCT06497504

Conditions
Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +20 more
Locations
  • GSK Investigational Site Bakersfield, California, United States
  • GSK Investigational Site San Francisco, California, United States
  • GSK Investigational Site Orlando, Florida, United States
  • GSK Investigational Site West Palm Beach, Florida, United States
View all 51 locations
View Trial Details
Active, Not Recruiting

A Study of Sequential Therapy With Daplusiran/Tomligisiran (DAP/TOM) Followed by Bepirovirsen in Participants Living With Chronic Hepatitis B (CHB)

NCT06537414

Conditions
Blood-Borne Infections, Chronic Disease, Chronic Hepatitis B Virus Infection, +15 more
Locations
  • GSK Investigational Site San Francisco, California, United States
  • GSK Investigational Site San Jose, California, United States
  • GSK Investigational Site Minneapolis, Minnesota, United States
  • GSK Investigational Site New York, United States
View all 80 locations
View Trial Details

Related conditions